Johnson & Johnson plans to have 100 million vaccines for Americans by spring, board member says

A J&J board member said “if the clinical trial works out,” the company could significantly increase the nation’s Covid vaccine supply availability.
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.